United Therapeutics Chairperson and CEO Martine Rothblatt disposes of 7,500 common shares for $3.93 million - UTHR News | RalliesUnited Therapeutics Chairperson and CEO Martine Rothblatt disposes of 7,500 common shares for $3.93 million
U
UTHR• Rothblatt trust exercises options and sells shares
- United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at $135.42.
- The trust then sold 8,500 shares at weighted average prices around $511.58 to $531.12.
- Trust holdings fell to 324,443 shares following the transactions on Aug. 27.
- The trust holds 46,910 stock options after the exercise.
